{"product_id":"comprehensive-review-of-radiation-oncology-2020-cme-videos","title":"Comprehensive Review of Radiation Oncology 2020 (CME VIDEOS)","description":"\u003ch2\u003eComprehensive Review of Radiation Oncology 2020 (CME VIDEOS)\u003c\/h2\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20.16px\"\u003eExplore Key Topics\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv id=\"tab-description\" class=\"woocommerce-Tabs-panel woocommerce-Tabs-panel--description panel entry-content active\" role=\"tabpanel\" aria-labelledby=\"tab-title-description\"\u003e\n\u003cdiv class=\"single-main-content\"\u003e\n\u003cp\u003e\u003cem\u003eComprehensive Review of Radiation Oncology\u003c\/em\u003e consists of 30 one-hour lectures spanning a wide range of radiation therapy treatments that require a complex set of processes: diagnosis, consultation, simulation, contouring target volumes and normal tissue structures, treatment planning, chart review, treatment delivery, quality assurance, and patient follow-up. Authoritative and clinically experienced faculty guide you to more efficient, safer, and higher quality care for each patient. This online CME program will help you to better:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eDescribe delivery speed and dose rates of FLASH radiation therapy\u003c\/li\u003e\n\u003cli\u003eList head and neck tumors for which radiotherapy is beneficial\u003c\/li\u003e\n\u003cli\u003eCompare radiotherapy for brain metastases and primary brain tumors\u003c\/li\u003e\n\u003cli\u003eSummarize differences in therapy for non-small versus small cell lung cancer\u003c\/li\u003e\n\u003cli\u003eDiscuss therapy for upper and lower GI malignancies\u003c\/li\u003e\n\u003cli\u003eContrast decision making involved in therapy after mastectomy and after breast conservation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eLearning Objectives\u003c\/h3\u003e\n\u003cp\u003eAt the conclusion of this activity, the participant should be able to:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eDescribe the delivery speed and dose rates of FLASH radiation therapy\u003c\/li\u003e\n\u003cli\u003eList the head and neck tumors for which radiotherapy is beneficial\u003c\/li\u003e\n\u003cli\u003eCompare radiotherapy for brain metastases with radiotherapy for primary brain tumors\u003c\/li\u003e\n\u003cli\u003eSummarize the differences in radiation therapy for non-small cell lung cancer and small cell lung cancer\u003c\/li\u003e\n\u003cli\u003eDiscuss radiation therapy for upper and lower gastrointestinal malignancies\u003c\/li\u003e\n\u003cli\u003eContrast the decision making involved in radiation therapy after mastectomy and after breast conservation\u003c\/li\u003e\n\u003cli\u003eExplain effective treatment delivery for gynecological tumors\u003c\/li\u003e\n\u003cli\u003eDifferentiate the treatment planning required for Hodgkin lymphoma and non-Hodgkin lymphoma\u003c\/li\u003e\n\u003cli\u003eCompare the doses and beams of various intensities used in stereotactic body radiation therapy used for primary and metastatic gastrointestinal tumors and spinal tumors\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eDate of Original Release:\u003c\/strong\u003e \u003cspan style=\"color: #ff0000\"\u003e\u003cstrong\u003eDecember 31, 2020\u003c\/strong\u003e\u003c\/span\u003e\u003cbr\u003e\n\u003cstrong\u003eDate Credits Expire:\u003c\/strong\u003e \u003cspan style=\"color: #ff0000\"\u003e\u003cstrong\u003eDecember 31, 2023\u003c\/strong\u003e\u003c\/span\u003e\u003cbr\u003e\n\u003cstrong\u003eEstimated time to complete:\u003c\/strong\u003e \u003cspan style=\"color: #ff0000\"\u003e\u003cstrong\u003e29.5 hours\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cem\u003e\u003cstrong\u003eTopics\/Speakers : \u003c\/strong\u003e\u003c\/em\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eProton Radiation Therapy in Adults – \u003cem\u003eThomas F. Delaney, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eImaging Applications in Radiation Therapy – \u003cem\u003eFang-Fang Yin, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eNon-Invasive Cardiac Radioablation for Ventricular Tachycardia – \u003cem\u003eClifford Robinson, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eFLASH \u0026amp; PHASER: Potential New Radiotherapy Paradigm and Its Clinical Translation – \u003cem\u003eBilly W. Loo, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eTreatment of Oligometastases in 2020 – \u003cem\u003eJoseph K. Salama, MD, FASTRO\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eImmunotherapy and Radiation Therapy – \u003cem\u003eYvonne M. Mowery, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003ePractical Radiotherapy Management for Brain Metastases – \u003cem\u003eScott R. Floyd, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eRadiation Therapy in the Treatment of Adult Primary Brain Tumors – \u003cem\u003eZachary J. Reitman, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eThe Role of PET Scanning in Head and Neck Cancer – \u003cem\u003eDavid M. Brizel, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eHead and Neck Tumors: HPV, Postop, Planning, Progression, Palliation – \u003cem\u003eYvonne M. Mowery, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eThoracic Tumors: Non-Small Cell Lung Cancer – \u003cem\u003eJoseph K. Salama, MD, FASTRO\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eSmall Cell Lung Cancer \u0026amp; Pleural Mesothelioma 2020 – \u003cem\u003eChris Kelsey, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eUpper Gastrointestinal Malignancies – \u003cem\u003eChristopher G. Willett, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eClinical Indications: Radiation\/SBRT for Liver Metastases and Hepatocellular Carcinoma – \u003cem\u003eBrian Czito, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eLower Gastrointestinal Cancers: Colon, Rectum, Anus – \u003cem\u003eManisha Palta, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eDefinitive Radiation Therapy for Prostate Cancer: Risk Stratification, Fractionation and Androgen Suppression – \u003cem\u003eW. Robert Lee, MD, MS, MEd, FASTRO, FABS\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eMulti-Disciplinary Care in Bladder Cancer: An Evidence-Based Review on the Role of Radiation Therapy – \u003cem\u003eStanley Liauw, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003ePost-Prostatectomy Radiation Therapy: Advances and Controversies – \u003cem\u003eDaniel E. Spratt, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eRadiotherapy in Breast Cancer: Decision Making After Mastectomy and Neoadjuvant Chemotherapy – \u003cem\u003eRachel C. Blitzblau, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eRadiotherapy in Breast Cancer: Decision Making After Breast Conservation – \u003cem\u003eSusan G. R. McDuff, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eSoft Tissue Sarcomas – \u003cem\u003eDavid Kirsch, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eNon-Hodgkin Lymphomas – \u003cem\u003eColin E. Champ, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eHodgkin Lymphoma 2020 – \u003cem\u003eChris Kelsey, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eLocally Advanced Cervical Cancer – \u003cem\u003eAkila N. Viswanathan, MD, MPH\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eGynecological Tumors: Uterine Cancer – \u003cem\u003eJunzo Chino, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eGynecological Tumors: Vaginal and Vulvar Cancer – \u003cem\u003eDiandra N. Ayala-Peacock, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003ePediatric Tumors I – \u003cem\u003eNicole Larrier, MD, MSc\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003ePediatric Tumors II – \u003cem\u003eNicole Larrier, MD, MSc\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eSkin Cancer – \u003cem\u003ePaul M. Busse, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eManagement of Spinal Metastases – \u003cem\u003eJohn P. Kirkpatrick, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e\n","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954652647522,"sku":"MED-AMB07582","price":15.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Comprehensive-Review-of-Radiation-Oncology-2020-CME-VIDEOS.jpg?v=1779381701","url":"https:\/\/meducourse.com\/products\/comprehensive-review-of-radiation-oncology-2020-cme-videos","provider":"Meducourse","version":"1.0","type":"link"}